Pancreatic Cancer

In this exclusive video, Monique van Leerdam, MD, and Matthias Löhr, MD, PhD, discuss possible preventions for pancreatic cancer.

In this exclusive video, Monique van Leerdam, MD, and Matthias Löhr, MD, PhD, discuss the need for better early detection of pancreatic cancer.

In this exclusive video, Monique van Leerdam, MD, and Matthias Löhr, MD, PhD, discuss the need for increased awareness about pancreatic cancer.

The FDA placed a clinical hold on a phase 1/phase 2 trial designed to evaluate BPX-601 — a chimeric antigen receptor T-cell therapy — followed by rimiducid for patients with previously treated metastatic pancreatic or prostate cancer.

Patients with pancreas ductal adenocarcinoma, compared with pancreatic cysts or normal pancreata, had changes in their duodenal fluid microbiome profiles, according to study results.

November is Pancreatic Cancer Awareness Month.

Pancreatic ductal adenocarcinoma historically has been a challenging cancer to treat, and often is not detected until it has progressed and metastasized. Some subtypes respond well to chemotherapy, whereas others are resistant.

The FDA granted fast track designation to devimistat for the treatment of pancreatic cancer, according to the agent’s manufacturer.

In a lecture dedicated to her sister’s memory, Katie Couric engaged in an honest and raw conversation with ACG President Mark Pochapin, MD, about how her grief over her husband’s death and then her sister’s spurred Couric into action and advocacy.

The FDA granted orphan drug designation to APX005M for the treatment of three gastrointestinal cancer types, according to the agent’s manufacturer.